OverviewChartProfileKey statisticsFinancialsNewsTraderScreen

Astellas Pharma, Inc./  US04623U1025  /

Nasdaq Other OTC
31/05/2024  21:59:40 Chg. +0.1200 Volume Bid- Ask- Market Capitalization Dividend Y. P/E Ratio
9.8100USD +1.24% 508,631
Turnover: 4.95 mill.		 -Bid Size: - -Ask Size: - 21.22 bill.USD - -
GlobeNewswire 09/05 Royalty Pharma Reports First Quarter 2024 Results
GlobeNewswire 30/04 Announcing More Customer Expansions
GlobeNewswire 16/04 Clearside Biomedical Appoints Seasoned Biotechnology Executive Anthony S. Gibney to its Board of Dir...
GlobeNewswire 19/03 Opthea to Host Key Opinion Leader Event on Sozinibercept (OPT-302) in Wet Age-Related Macular Degene...
GlobeNewswire 11/03 FibroGen Appoints Deyaa Adib, M.D. as Chief Medical Officer
GlobeNewswire 29/02 4DMT Reports Full Year 2023 Financial Results and Operational Highlights
GlobeNewswire 26/02 FibroGen Regains All Rights to Roxadustat from AstraZeneca in the United States and Other AstraZenec...
GlobeNewswire 14/02 Iktos opens a subsidiary in Japan and entrusts its management to Hideyoshi Fuji
GlobeNewswire 07/02 LAPIX Therapeutics Strengthens Board of Directors with Appointments of Pharmaceutical Industry Veter...
GlobeNewswire 05/02 MBX Biosciences Appoints Steven Ryder, M.D., to Board of Directors
GlobeNewswire 01/02 PRISM MarketView Marks World Cancer Day
GlobeNewswire 23/01 Vivtex Enters Research Collaboration with Astellas Pharma
GlobeNewswire 11/12/2023 Basilea announces that FDA approves expanded use of antifungal Cresemba® (isavuconazole) in the Unit...
Newsfile Corp 26/10/2023 Zenith Epigenetics Ltd. Announces Collaboration with Cencora on ZEN-3694
TeleTrader 19/10/2023 Report: China arrests Japanese man on espionage charges
GlobeNewswire 19/10/2023 Basilea announces acquisition of novel clinical-stage antifungal for treatment of Aspergillus mold i...
GlobeNewswire 14/09/2023 Mineralys Therapeutics Expands its Board of Directors with Appointments of Glenn Sblendorio and Daph...
GlobeNewswire 11/09/2023 Eledon Pharmaceuticals Appoints Industry Veteran James Robinson to its Board of Directors
GlobeNewswire 30/08/2023 Sutro Biopharma to Participate in Upcoming Investor Conferences
Newsfile Corp 01/06/2023 Zenith Epigenetics Reports Advancement of ZEN-3694 in NUT Carcinoma
TeleTrader 01/05/2023 Astellas Pharma acquires Iveric Bio for $5.9 billion
GlobeNewswire 11/03/2022 ENTA Conducting Clinical Trial of Investigational Regenerative Medication to Restore Hearing Functi...
GlobeNewswire 28/02/2022 Vallon Pharmaceuticals Announces Appointment of Meenu Karson to Board of Directors
GlobeNewswire 22/02/2022 Zenith Epigenetics Announces Dosing of First Cancer Patient with a Combination of ZEN-3694 + Bristol...
GlobeNewswire 31/01/2022 Zenith Epigenetics Announces Appointment to Board of Directors and Provides Clinical Update